Todd S. Werner

Todd S. Werner is a Partner and Founder at Avantech Law, LLP, focusing his practice on complex patent disputes across diverse technological fields.

Mr. Werner maintains a versatile patent litigation practice, representing both plaintiffs and defendants. While his tracked appearances include leading eight plaintiff-side cases, often for non-practicing entities (NPEs) like AutoConnect Holdings LLC and Weple IP Holdings LLC, his firm profile highlights significant defense work for operating companies. For plaintiffs, his work has involved asserting patents related to network-connected vehicles, in-vehicle multimedia systems, facial identification, digital keys, and Apple CarPlay/Android Auto platforms against major automotive manufacturers such as Hyundai, Toyota, and Ford. He has also represented Weple IP Holdings LLC in litigation concerning streaming content technology against Meta Platforms Inc. On the defense side, leveraging his biochemistry background, Mr. Werner has nearly two decades of experience representing pharmaceutical companies in Abbreviated New Drug Application (ANDA) litigation. Notably, he led efforts to defeat a patent covering Biogen's Tecfidera® product and assisted Teva Pharmaceuticals in successfully challenging patents for abuse-deterrent opioid products. His experience also spans other life sciences, electrical, mechanical, and chemical arts.

Mr. Werner possesses substantial experience in Post-Grant Review (PGR) and Inter Partes Review (IPR) proceedings before the Patent Trial and Appeal Board (PTAB). He has successfully defended a client's patent in IPR proceedings, securing a favorable settlement, and achieved significant victories challenging patents, such as securing invalidity judgments on 114 of 117 claims in IPRs against Schlumberger patents in M-I Drilling Fluids UK Ltd. v. Dynamic Air Inc., which led to a $1.4 million attorney fee recovery. His involvement in cases like Unified Patents v. AutoConnect Holdings LLC further underscores his PTAB experience.

He earned a degree in biochemistry, which underpins his extensive work in pharmaceutical and life sciences patent litigation.